Data from 10,000 individuals affected by SARS-CoV-2 will be used to identify biomarkers that can help predict potential risk of serious disease and support the development of novel therapeutics to combat COVID-19 SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced that its world-class sequencing and bioinformatics solutions are being used by HostSeq, part of […]
ArchiMed and Cube management will expand sales in the US – the world’s largest drug discovery market – and broaden Cube’s product and service offering organically and via acquisitions. Trans-Atlantic private equity healthcare specialist ArchiMed has purchased a majority stake in Monheim, Germany-based Cube. Founded in 2012, Cube has developed proprietary methods and products to […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced the commercial availability of GMP-grade materials manufactured at its St. Paul, MN GMP (Good Manufacturing Practices) manufacturing facility. The facility is dedicated to supporting large-scale production of GMP-grade proteins, including animal-free cytokines and growth factors, that are essential components of cell culture media for immuno-oncology, regenerative medicine […]
SAN DIEGO — Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the release of Bionano Solve™ version 3.7 and Bionano Access™ version 1.7 as available data solution upgrades for Saphyr systems installed in laboratories worldwide. Included in these […]
I2 Investigators will leverage CODEX technology and the expertise of Akoya and its partners as they push the boundaries of spatial biology. MARLBOROUGH, Mass. — Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced the first members of the Akoya Imaging Innovators (I²) Network, a collaboration of pioneering scientists from world-class research organizations, with ambitions […]
Funds to drive commercial expansion as growing number of facilities bring genomics into communities worldwide ST. LOUIS, MO — PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to […]
CAMBRIDGE, Mass. — Ultivue announces the addition of Steve Pemberton in the role of SVP Commercial Development, as the company adds to its growing executive team. Steve is a seasoned commercial executive with 25 years of experience building and leading high performing sales and marketing teams. Steve was most recently the Vice President, Commercial Development […]
Former product innovator at BGI, Illumina, and Pacific Biosciences will spearhead technological development of breakthrough Molecular Cartography™ system MONHEIM AM RHEIN, Germany — Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the appointment of Frank Zhong, PhD, as Chief Technology Officer. In this role, Zhong will report to Co-founder and CEO Jason T. Gammack […]
Arul Chinnaiyan and Sten Linnarsson to bolster Rebus expertise and scientific direction SANTA CLARA, Calif. — Rebus Biosystems Inc., (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, today announced that Drs. Arul Chinnaiyan, MD, PhD, and Sten Linnarsson, PhD, have been appointed to the Company’s […]
Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology
– Enabling solutions for biopharmaceutical development and production – Tokyo, Japan – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services. Fostering the development of the bioeconomy is one of the priority issues within Yokogawa’s sustainability goals, […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
